ONCYONCOLYTICS BIOTECH INCvs its industry peers
A metric-by-metric comparison of ONCOLYTICS BIOTECH INC against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCYThis | $101M#3 | — | — | — | — | -26.2%#6 | — | — | — | — | — | — |
| NVS | $268.2B#1 | — | 5.8x#1 | — | — | 17.1%#4 | — | 30.3%#1 | — | — | — | 2.9%#1 |
| NVSEF | — | — | — | — | — | 17.1%#4 | — | 30.3%#1 | — | — | — | — |
| NWBO | — | — | — | — | -0.3%#1 | 28.2%#3 | -4347.9%#1 | — | -721.5%#1 | — | — | — |
| OCEA | $5M#5 | — | — | — | — | 91.7%#2 | — | — | — | — | — | — |
| OGI | $118M#2 | — | — | — | — | — | — | — | — | — | — | — |
| PBM | $15M#4 | — | — | — | — | 102.0%#1 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice